SEC Form 4 · accession 0001209191-15-004038
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pankaj Bhargava
Officer — Chief Medical Officer
Period of report
Jan 9, 2015
Accepted (ET)
Jan 13, 2015 · 8:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $18.50 | Jan 9, 2015 | A | 56,250 | A | — | Jan 9, 2025 | Common Stock | 56,250 | 56,250 | D |
Explanation of responses
- F1The option vests in 48 monthly installments over the four-year period with a vesting start date of January 9, 2015, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.